Renji Hospital

This study tests a new treatment for high-risk bladder cancer that hasn't spread into the muscle. The treatment uses a harmless virus (adenovirus) put directly into the bladder to attack cancer cells. About 18 people will receive different doses to find the safest and most effect…

This study looks at two ways to treat people with a certain type of heart attack (NSTE-ACS) who have multiple blocked heart arteries. One group gets all blockages fixed during the emergency procedure, while the other group fixes only the main blockage first and the rest later. Th…

This study tests a new drug (JS004) combined with toripalimab in 31 adults with advanced kidney cancer that got worse after prior immunotherapy. The goal is to see if the combination can shrink tumors or stop them from growing. Participants receive treatment for up to 2 years, an…

This study tests a device called a flow diverter to treat brain aneurysms that are not the common balloon-like type. The goal is to block blood flow into the aneurysm to prevent it from rupturing. About 168 adults aged 18 to 80 will receive the device and be followed for 12 month…

This early-stage study tests a new treatment called BEN301 for people with autoimmune diseases like scleroderma, rheumatoid arthritis, Sjogren's syndrome, and inflammatory muscle diseases. The therapy uses specially engineered immune cells (CAR-Tregs) to calm the overactive immun…

This study tests whether a non-invasive brain stimulation technique called transcranial magnetic stimulation (TMS) can reduce the time older adults spend confused after heart surgery. About 144 patients aged 50 and older who develop delirium after their operation will receive eit…

This study tests whether a smartwatch with artificial intelligence can help doctors monitor heart attack patients after they leave the hospital. About 200 adults who had a heart attack and a stent placed will wear a smartwatch for 3 months. The goal is to see if the AI can predic…